Baricitinib is Effective in Treating Progressing Vitiligo in vivo and in vitro

• Päätekijät: Jie Dong (Tekijä), Xuan Huang (Tekijä), Li-Ping Ma (Tekijä), Fei Qi (Tekijä), Si-Nian Wang (Tekijä), Zi-Qin Zhang (Tekijä), Shi-Nan Wei (Tekijä), Ling Gao (Tekijä), Fang Liu (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: SAGE Publishing, 2022-04-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Objective To evaluate the clinical efficacy and safety of baricitinib, a Janus kinase (JAK) inhibitor, in treating patient with progressing vitiligo, and to further explore the regulation of baricitinib on melanocytes (MCs) in vitro. Methods Four patients with progressing vitiligo were treated with...